Stephan Buse

Dr. Stephan Buse

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 May 2018 in The International Journal of Medical Robotics and Computer Assisted Surgery
Verified
Journal Article
Closed access
PDF file
SBStephan Buse
Stephan Buse
CHCarolin E. Hach
Carolin E. Hach
PKPhillip Klumpen
Phillip Klumpen
KSKaroline Schmitz
Karoline Schmitz
RMRene Mager
Rene Mager
AHAxel Haferkamp
Axel Haferkamp

12 December 2015 in World Journal of Urology
Verified
Journal Article
Closed access
PDF file
SBStephan Buse
Stephan Buse
CHCarolin E. Hach
Carolin E. Hach
PKPhillip Klumpen
Phillip Klumpen
AAAssen Alexandrov
Assen Alexandrov
RMRene Mager
Rene Mager
AHAxel Haferkamp
Axel Haferkamp

4 February 2013 in International Journal of Urology
Verified
Journal Article
Closed access
PDF file
SBStephan Buse
Stephan Buse
THThomas Höfner
Thomas Höfner
SMStephan C Müller
Stephan C Müller
EHEdwin Hermann
Edwin Hermann
WWWolf F Wieland
Wolf F Wieland
AHAxel Haferkamp
Axel Haferkamp

25 September 2023 in Die Urologie
Verified
Journal Article
Closed access
PDF file
CKChristoph Kowalski
Christoph Kowalski
NSNora Tabea Sibert
Nora Tabea Sibert
PHPeter Hammerer
Peter Hammerer
SWSimone Wesselmann
Simone Wesselmann
GFGünter Feick
Günter Feick
MBMartin Burchardt
Martin Burchardt

28 April 2021 in BMC Urology
Verified
Journal Article
Open access
PDF file
SBStephan Buse
Stephan Buse
AAAssen Alexandrov
Assen Alexandrov
EMElio Mazzone
Elio Mazzone
AMAlexandre M. Mottrie
Alexandre M. Mottrie
AHAxel Haferkamp
Axel Haferkamp
Background: Simultaneous urothelial cancer manifestation in the lower and upper urinary tract affects approximately 2% of patients. Data on the surgical benchmarks and mid-term oncological outcomes of enbloc robot-assisted radical cystectomy and nephro-ureterectomy are scarce. Methods: After written informed consent was obtained, we prospectively enrolled consecutive patients undergoing enbloc radical cystectomy and nephro-ureterectomy with robotic assistance from the DaVinci Si-HD® system in a prospective institutional database and collected surgical benchmarks and oncological outcomes. Furthermore, as one console surgeon conducted all the procedures, whereas the team providing bedside assistance was composed ad hoc, we assessed the impact of this approach on the operative duration. Results: Nineteen patients (9 women), with a mean age of 73 (SD: 7.5) years, underwent simultaneous enbloc robot-assisted radical cystectomy and nephro-ureterectomy. There were no cases of conversion to open surgery. In the postoperative period, we registered 2 Clavien-Dindo class 2 complications (transfusions) and 1 Clavien-Dindo class 3b complication (port hernia). After a median follow-up of 23 months, there were 3 cases of mortality and 1 case of metachronous urothelial cancer (contralateral kidney).The total operative duration did not decrease with increasing experience (r = 0.174, p = 0.534). In contrast, there was a significant, inverse, strong correlation between the console time relative to the total operative duration and the number of conducted procedures after adjusting for the degree of adhesions and the type of urinary diversion(r = -0.593, p = 0.02). Conclusions: These data suggest that en bloc simultaneous robot-assisted radical cystectomy and nephro-ureterectomy can be safely conducted with satisfactory mid-term oncological outcomes. With increasing experience, improved performance was detectable for the console surgeon but not in terms of the total operative duration. Simulation training of all team members for highly complex procedures might be a suitable approach for improving team performance. Trial registration: Not applicable.

1 November 2023 in Journal of Endourology
Verified
Journal Article
Closed access
JRJordan M. Rich
Jordan M. Rich
NTNeeraja Tillu
Neeraja Tillu
RGRalph Grauer
Ralph Grauer
DBDallin Busby
Dallin Busby
RARebecca Auer
Rebecca Auer
HJHubert John
Hubert John
Background: Robot-assisted repair of benign ureteroenteric anastomotic strictures (UAS) provides an alternative to the open approach. We aimed to report short-, medium-, and long-term outcomes for robotic repair of benign UAS, and to provide a detailed video demonstration of critical operative techniques in performing this procedure robotically. Materials and Methods: Between January 2013 and September 2022, 31 patients from seven institutions who previously underwent radical cystectomy and subsequently developed UAS underwent robotic repair of UAS. Perioperative variables were prospectively collected, and postoperative outcomes were assessed. The surgery starts with a lysis of adhesions after previous surgery. Ureters are dissected, and the level of the stricture is identified. The ureter is then divided, and the stricture is resected. Finally, the ureter is spatulated and reimplanted with Nesbit technique after stenting with Double-J stents. In cases where both ureters show strictures, Wallace technique for reimplantation can be applied. Results: After robotic or open cystectomy, 31 patients had a total of 43 UAS at a median (interquartile range) follow-up of 21 (9–43) months. Median stricture length was 2.0 (1.0–3.25) cm, operative duration was 141 (121–232) minutes, estimated blood loss was 100 (50–150) mL, and length of hospital stay was 5 (3–9) days. One (3.2%) case was converted to open and one (3.2%) intraoperative complication occurred. Seven (22.6%) patients experienced postoperative complications, including four (12.9%) Clavien–Dindo grade 3 complications. No Clavien–Dindo grade 4 or 5 complications occurred. Stricture recurrence occurred in 2 (6.5%) patients. Conclusions: These results demonstrate that robotic repair of UAS is feasible and effective approach with outcomes in line with prior open series. Patient Consent Statement: Authors have received and archived patient consent for video recording and publication in advance of video recording of procedure.